Hangzhou, China

Xiaoxiao Chen

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hangzhou Dac Biotech Co., Ltd. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaoxiao Chen. Retrieved from https://idiyas.com/inventor/xiaoxiao-chen-0lsq5tfo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Xiaoxiao Chen in Biotech

Introduction

Xiaoxiao Chen is a prominent inventor based in Hangzhou, China. She has made significant contributions to the field of biotechnology, particularly in the development of formulations for targeted treatments. Her work focuses on innovative solutions for complex medical challenges.

Latest Patents

Xiaoxiao Chen holds a patent for the formulation of a conjugate of a tubulysin analog to a cell-binding molecule. This formulation is designed for targeted treatment of cancer, autoimmune diseases, and infectious diseases. The patent details a structure represented by Formula (I), which includes various components defined within the patent documentation.

Career Highlights

Xiaoxiao Chen is associated with Hangzhou Dac Biotech Co., Ltd., where she applies her expertise in biotechnology. Her innovative approach has led to advancements in therapeutic formulations, showcasing her commitment to improving healthcare outcomes.

Collaborations

Xiaoxiao collaborates with notable colleagues, including Robert Zhao and Qingliang Yang. These partnerships enhance her research and development efforts, contributing to the success of her projects.

Conclusion

Xiaoxiao Chen's work exemplifies the impact of innovation in biotechnology. Her contributions are paving the way for new treatment options that address critical health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…